Orthofix International | OFIX - Operating Expenses


Orthofix International reported $213.79M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 143.94M 3.22M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
EDAP TMS EUR 25.18M 6.37M Mar/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
J&J USD 17.83B 388M Jun/2026
Medtronic USD 7.92B 203M Jun/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Smith & Nephew USD 2.59B 71M Jun/2026
STAAR Surgical USD 83.43M 7.32M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Veracyte USD 126.36M 6.37M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026